ORELOX for children and for infants 40 mg/5 ml, granules for oral suspension bottle, 8.35 g
Active ingredients: Cefpodoxime, Cefpodoxime proxetil
Commercialized according to BDPMDispensing in France: Prescription only
Granules for oral suspensionbottle, 8.35 gorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ORELOX ENFANTS ET NOURRISSONS 40 mg/5 ml, granulés pour suspension buvable
- Pharmaceutical form
- granulés pour suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre de 8,35 g - avec seringue pour administration orale
- Marketing authorisation holder
- TEOFARMA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 10 Nov 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61923059CIP73360383CIP133400933603830Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CEFPODOXIMEgranulés | 4,800 g · 100 g de granulés | FT |
| CEFPODOXIME PROXÉTILgranulés | 6,261 g · 100 g de granulés | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.